F5 Networks Beats Q3 Estimates But Issues Upbeat Q4 Outlook

F5 Networks Beats Q3 Estimates But Issues Upbeat Q4 Outlook
July 31, 2024

Video Source: F5, Inc. on YouTube

 

F5, Inc. (Nasdaq: FFIV) reported better-than-anticipated fiscal 2024 third-quarter earnings and revenues. The tech giant also issued a higher-than-expected fourth-quarter outlook. The stock of F5 ended Tuesday’s trading session at $200.66, up $23.07, or 12.99%, from the prior close.

The company, based in Seattle, Washington, announced third-quarter revenues of $695.50 million, showing a 1% decline from $702.64 million in the corresponding quarter ending June 30, 2023.

For the third quarter, which ended June 30, 2024, F5 posted net income of $144.08 million, or $2.44 per share, compared with $88.98 million, or $1.48 per share, in the quarter that ended on June 30, 2023.

Excluding expenses related to stock-based compensation, amortization and impairment of purchased intangible assets, costs associated with facility exits, charges related to acquisitions, and restructuring expenses, among others, F5 recorded 3Q 2024 net income of $198.84 million, or $3.36 per share, an increase from $193.65 million, or $3.21 per share, in 3Q 2023.

Analysts surveyed by LSEG anticipated F5 would report earnings of $2.97 per share, alongside revenues amounting to $686.10 million.

Commenting on the results, François Locoh-Donou, F5’s President and CEO, stated “We delivered third-quarter revenue at the top end of our guidance range fueled by software growth and continued growth of our global services offerings. In addition, our continued operating discipline enabled us to deliver earnings per share well above the high end of our guidance.”

Segment wise:

  • Product revenues amounted to $308.49 million, showing a 6% year-over-year decline.
  • Services revenues increased by 3.30% year-over-year to $387.01 million.

Regarding the business nature:

  • Software revenues increased by 3% year-over-year to $179 million.
  • Systems revenue decreased by 16% year-over-year to $130 million.
  • Global services revenues reached $387 million, marking a 3% increase compared to the previous year.

For the third quarter of 2024, F5 recorded a non-GAAP gross margin of 83.10%, up from 82.50% last year.

Looking ahead, F5 expects fourth-quarter revenues to range from $720 million to $740 million. The company also forecasts fourth-quarter earnings to be between $3.38 and $3.50 per share.

Wall Street analysts anticipate F5 to report earnings of $3.33 per share on revenues of $717.40 million.

The earnings for the quarter beat and robust Q4 outlook are expected to keep the stock in F5 slightly bullish in the short term.

The historical price chart indicates that the stock of F5 has broken the resistance at $195. The stock is also trading above its 50-day moving average, while the MACD indicator is showing a positive reading. Therefore, we anticipate F5’s stock to remain in an uptrend in the near term.

F5 - technical analysis - 31 July 2024

Disclaimer: Any financial trading analysis offered here is our opinion and is not intended as advice or direction for investors. We cannot guarantee the success of any trades made as a consequence of this article, and we encourage traders to incorporate a strong money management strategy to limit losses when they enter the markets. Please use this article as part of your own research before formulating strategies prior to trading.

Andrew Wright

Prior to founding tradersasset.com in 2014, Andrew worked as a proprietary trader, then as a market maker. As a market maker, he traded options in over 100 stocks, he then began trading currency pairs in 2013. Andrew still actively trades both, and prides himself on educating and informing traders on the benefits of both Binary Options and Forex.


Related Articles

FDA Allows Pharmacists to Prescribe Pfizer’s COVID-19 Pill

Video Source: ABC News on YouTube   Pfizer Inc. (NYSE: PFE) grabbed the market’s attention yesterday after the US FDA

JP Morgan Reports First Earnings Miss In 15 Quarters

  The stock of JPMorgan Chase & Co. (NYSE: JPM) closed nearly flat at $101.68 yesterday, after the investment banking

Walgreens Swings to Loss in Q4, Issues Firm FY 2023 EPS View

Video Source: CNBC Television on YouTube   Pharmacy chain Walgreens Boots Alliance Inc (Nasdaq: WBA) reported a swing to a